Cardiovascular Diseases Clinical Trial
— IMPACT-CROfficial title:
Improving Physical Activity and Cardiac Rehabilitation Attendance Using Technology and Behavioral Economics
Verified date | October 2023 |
Source | University of Pennsylvania |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of this study is to test the feasibility of using behavioral economic interventions (gamification with and without loss-framed financial incentives) targeting daily steps counts to improve cardiac rehabilitation attendance.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | December 31, 2024 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age greater than 18; - Ability to consent; - Patients with diagnosis of stable angina, chronic systolic heart failure, post- percutaneous coronary intervention, post-coronary artery bypass grafting surgery, post-acute myocardial infarction, and post-valvular repair who were discharged after an inpatient admission within the last 12 months; - Smartphone or tablet compatible with application for the wearable activity tracking device; - Independence Blue Cross health insurance coverage. Exclusion Criteria: - Conditions that would make participation infeasible such as inability to provide informed consent, illiteracy or inability to speak, read, and write English; - Already enrolled in another study targeting physical activity; - Medical condition preventing participation in a physical activity program; - Prior or ongoing enrollment in cardiac rehabilitation; - Baseline step count > 7,500 steps per day |
Country | Name | City | State |
---|---|---|---|
United States | Perelman Center for Advanced Medicine | Philadelphia | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
University of Pennsylvania | National Institute on Aging (NIA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Proportion of participants that identified a support partner | We will explore measures of intervention acceptability and feasibility including the proportion of participants that identified a support partner. | Baseline to 12-week intervention period | |
Other | Proportion of participants that completed the entire study | We will explore measures of intervention acceptability and feasibility including the proportion of participants that completed the entire study. | Baseline to 12-week intervention period | |
Other | Proportion of days that wearable device was used | We will explore measures of intervention acceptability and feasibility including the proportion of days that the wearable device was used. | Baseline to 12-week intervention period | |
Primary | Number of cardiac rehabilitation sessions attended during intervention | The primary outcome is the number of CR sessions attended during the 12-week intervention period. | Baseline to 12-week intervention period | |
Secondary | Proportion of patients that attend 30 of the 36 cardiac rehabilitation sessions during intervention | The secondary outcome includes the proportion of patients that attend at least 30 of the 36 CR sessions during the 12-week intervention period. | Baseline to 12-week intervention period | |
Secondary | Change in mean daily step counts from baseline to 12-week period | The secondary outcomes include the change in daily step counts from baseline to the 12-week intervention period. | Baseline to 12-week intervention period |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|